Together with 16 partners, AmsterdamUMC will use artificial intelligence techniques, big data, proteomics, genomics and lipodomics to predict cardiovascular mortality and morbidity and progression of vascular diseases in patients with AAA or PAD. Next to prediction, there will be a large validation cohort to evaluate the results. Ethical concerns of using AI and implementing AI will have special attention in the project. Read more here.
